TWD 64.7
(0.47%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 113.97 Million TWD | -58.7% |
2022 | 275.96 Million TWD | 57.63% |
2021 | 175.07 Million TWD | 0.95% |
2020 | 173.43 Million TWD | 199.3% |
2019 | 57.94 Million TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 40.98 Million TWD | 13.51% |
2024 Q2 | 43.43 Million TWD | 5.97% |
2023 Q4 | 36.11 Million TWD | -16.01% |
2023 FY | 113.97 Million TWD | -58.7% |
2023 Q3 | 42.99 Million TWD | 24.02% |
2023 Q2 | 34.66 Million TWD | 17588.27% |
2023 Q1 | 196 Thousand TWD | -97.17% |
2022 FY | 275.96 Million TWD | 57.63% |
2022 Q4 | 6.91 Million TWD | 0.0% |
2021 FY | 175.07 Million TWD | 0.95% |
2020 FY | 173.43 Million TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Allied Biotech Corporation | 246.43 Million TWD | 53.752% |
GeneFerm Biotechnology Co., Ltd. | 286.35 Million TWD | 60.198% |
Easywell Biomedicals, Inc. | 170.71 Million TWD | 33.24% |
TTY Biopharm Company Limited | 3.22 Billion TWD | 96.465% |
Synmosa Biopharma Corporation | 2.11 Billion TWD | 94.624% |
Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | 94.692% |
Center Laboratories, Inc. | 618.09 Million TWD | 81.561% |
Tien Liang BioTech Co., Ltd. | 286.14 Million TWD | 60.17% |
Orient Pharma Co., Ltd. | 468.66 Million TWD | 75.682% |
InnoPharmax Inc. | 17.45 Million TWD | -552.873% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | 53.411% |
Excelsior Biopharma Inc. | 306.93 Million TWD | 62.867% |
DV Biomed Co., Ltd. | 764.27 Million TWD | 85.088% |
Handa Pharmaceuticals, Inc. | 1.1 Billion TWD | 89.686% |
UniPharma Co., Ltd. | 51.01 Million TWD | -123.404% |
Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | 71.287% |
Alar Pharmaceuticals Inc. | 465.92 Million TWD | 75.538% |
Winston Medical Supply Co., Ltd. | 347.59 Million TWD | 67.212% |
Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -19152.027% |
Bioray Biotech Co., Ltd | 77.65 Million TWD | -46.775% |
TSH Biopharm Corporation Limited | 399.89 Million TWD | 71.5% |